Ikonisys SA (ALIKO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ikonisys SA (ALIKO) has a cash flow conversion efficiency ratio of -0.016x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-257.48K ≈ $-301.02K USD) by net assets (€15.73 Million ≈ $18.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ikonisys SA - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Ikonisys SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Ikonisys SA carry for a breakdown of total debt and financial obligations.
Ikonisys SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ikonisys SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blackrock World Mining Trust Plc
LSE:BRWM
|
0.012x |
|
Nucletron Electronic Aktiengesellschaft
F:NUC
|
0.004x |
|
SUNDRAGON S.A. ZY-1
F:6EI
|
N/A |
|
Yonga Mobilya Sanayi ve Ticaret AS
IS:YONGA
|
-0.317x |
|
Rubicon Water Ltd
AU:RWL
|
0.051x |
|
Naas Technology Inc ADR
NASDAQ:NAAS
|
-0.015x |
|
VIP Clothing Limited
NSE:VIPCLOTHNG
|
0.094x |
|
Kota Satu Properti Tbk PT
JK:SATU
|
0.014x |
Annual Cash Flow Conversion Efficiency for Ikonisys SA (2020–2024)
The table below shows the annual cash flow conversion efficiency of Ikonisys SA from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see ALIKO market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €14.25 Million ≈ $16.66 Million |
€-1.33 Million ≈ $-1.55 Million |
-0.093x | -60.43% |
| 2023-12-31 | €15.73 Million ≈ $18.39 Million |
€-914.22K ≈ $-1.07 Million |
-0.058x | +9.72% |
| 2022-12-31 | €17.67 Million ≈ $20.66 Million |
€-1.14 Million ≈ $-1.33 Million |
-0.064x | -64.86% |
| 2021-12-31 | €20.01 Million ≈ $23.40 Million |
€-781.42K ≈ $-913.56K |
-0.039x | +85.34% |
| 2020-12-31 | €5.70 Million ≈ $6.66 Million |
€-1.52 Million ≈ $-1.77 Million |
-0.266x | -- |
About Ikonisys SA
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more